Day One shareholders elect two Class I directors, ratify PwC, approve say-on-pay at 2025 meeting

Day One Biopharmaceuticals, Inc.

Natalie Holles elected with 81,975,302 shares for (98.4% of votes cast); Garry Nicholson elected with 65,553,238 for (78.7%).
Ratification of PricewaterhouseCoopers as fiscal 2025 auditor passed with 89,705,033 shares for (99.9% of votes cast).
Non-binding advisory vote on named executive officer compensation approved with 82,385,592 for (98.9% of votes cast).
All proposals passed with requisite majority; broker non-votes of 6,470,934 on director elections and say-on-pay.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.